V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10438628 | 10033301 | 1.51 | 107.5 | 02 | 2017-05-04 | 2017-05-07 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100834204 |
| 10438633 | 10033302 | 1.68 | 72 | Palliative (P) | 2021-04-19 | 2021-05-10 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100621336 |
| 10438640 | 10033303 | 1.85 | 114 | Curative (C) | 2020-07-26 | 2020-11-03 | Capecitabine | 02 | N | CAPECITABINE | 100827335 |
| 10438641 | 10033304 | null | 75.4 | null | 2022-05-24 | 2022-05-24 | Capecitabine + Oxaliplatin 21day | 02 | null | PEMBROLIZUMAB | 101327034 |
| 10438653 | 10033305 | 1.78 | 89 | Curative (C) | 2016-12-16 | 2016-12-16 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101068891 |
| 10438663 | 10033306 | 1.54 | 45.6 | null | 2021-05-22 | 2021-07-03 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100832800 |
| 10438668 | 10033307 | 1.72 | 65.5 | null | 2018-09-21 | 2018-10-09 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101687145 |
| 10438675 | 10033308 | 1.81 | 85.5 | Palliative (P) | 2018-02-24 | 2018-03-03 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101162206 |
| 10438690 | 10033309 | 1.64 | 108.6 | Adjuvant (A) | 2016-07-27 | 2016-08-13 | Docetaxel | 02 | N | DOCETAXEL | 100186229 |
| 10438762 | 10033310 | 0 | 81 | null | null | null | Rituximab | 02 | N | RITUXIMAB | 101526524 |
| 10438804 | 10033311 | 1.77 | 64 | null | 2018-11-25 | 2018-12-08 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101078091 |
| 10438808 | 10033312 | 1.52 | 81 | null | 2017-09-13 | 2017-09-23 | Rituximab | 02 | null | RITUXIMAB | 101025684 |
| 10438812 | 10033313 | null | 73.2 | null | 2022-01-07 | 2022-01-07 | IBRUTINIB | 02 | null | IBRUTINIB | 101841145 |
| 10438861 | 10033314 | 1.75 | 85.1 | Adjuvant (A) | 2021-09-01 | 2021-09-17 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 101676548 |
| 10438890 | 10033315 | 1.62 | 60 | null | 2021-03-10 | 2021-03-28 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100654735 |
| 10438896 | 10033316 | 1.82 | 75 | null | 2021-09-08 | 2021-09-09 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100424260 |
| 10438899 | 10033317 | 1.72 | 78.7 | Adjuvant (A) | 2021-06-04 | 2021-06-05 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100243223 |
| 10438911 | 10033318 | 1.49 | 76.8 | Curative (C) | 2016-04-16 | 2016-04-25 | Capecitabine + Oxaliplatin 21day | N | N | DOCETAXEL | 101011168 |
| 10438914 | 10033319 | 1.58 | 59 | null | 2019-07-29 | 2019-08-24 | Capecitabine | 02 | null | CAPECITABINE | 100787317 |
| 10438915 | 10033320 | 1.75 | 68.9 | Palliative (P) | 2017-10-01 | 2017-10-08 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100163580 |
| 10438922 | 10033321 | null | 105.75 | Curative (C) | 2017-03-08 | 2017-04-05 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 101699795 |
| 10438931 | 10033322 | 1.62 | 70.2 | Palliative (P) | 2017-05-17 | 2017-05-21 | Capecitabine + Oxaliplatin 21day | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100468680 |
| 10438944 | 10033323 | 1.57 | 72 | Adjuvant (A) | 2018-04-28 | 2018-05-09 | CHOP R | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100497420 |
| 10438958 | 10033324 | 1.76 | 93 | Palliative (P) | 2017-03-05 | 2017-03-17 | CAPECITABINE + OXALIPLATIN | 02 | Y | PEMBROLIZUMAB | 100904186 |
| 10438969 | 10033325 | 1.74 | 80 | Palliative (P) | 2016-03-29 | 2016-05-08 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100989563 |
| 10438972 | 10033326 | 1.67 | 72.4 | Palliative (P) | 2014-10-17 | 2016-11-24 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101618673 |
| 10438978 | 10033327 | 1.77 | 89.2 | null | 2022-05-21 | 2022-05-27 | Docetaxel | 02 | null | DOCETAXEL | 101358341 |
| 10438981 | 10033328 | 1.58 | 67 | null | 2018-07-17 | 2018-07-31 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100786508 |
| 10438988 | 10033329 | 1.62 | 74 | Neo-adjuvant (N) | 2020-08-01 | 2020-08-12 | Rituximab | 02 | null | RITUXIMAB | 101789759 |
| 10439012 | 10033330 | 1.83 | 71 | Palliative (P) | 2020-12-27 | 2021-03-29 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 101871410 |
| 10439014 | 10033331 | 1.75 | 78 | Palliative (P) | 2018-02-08 | 2018-02-10 | Rituximab | N | N | RITUXIMAB | 101205947 |
| 10439016 | 10033332 | 1.76 | 64 | Adjuvant (A) | 2018-05-07 | 2018-05-11 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101574903 |
| 10439021 | 10033333 | 1.65 | 44 | Palliative (P) | 2014-02-25 | 2014-02-25 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100112506 |
| 10439030 | 10033334 | 1.64 | 48 | Palliative (P) | 2017-09-26 | 2017-10-10 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101415134 |
| 10439035 | 10033335 | 1.84 | 60.4 | null | 2019-08-22 | 2019-09-10 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101203896 |
| 10439042 | 10033336 | 1.55 | 101 | Palliative (P) | 2019-07-02 | 2019-07-19 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101464936 |
| 10439053 | 10033337 | 1.75 | 72.9 | Adjuvant (A) | 2018-08-28 | 2018-09-05 | Capecitabine | 02 | N | CAPECITABINE | 100784858 |
| 10439085 | 10033338 | 1.75 | 36 | null | 2014-01-06 | 2016-05-31 | IBRUTINIB | 02 | null | IBRUTINIB | 101346158 |
| 10439119 | 10033339 | 1.75 | 66.9 | Palliative (P) | 2014-03-27 | 2014-04-06 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101096621 |
| 10439129 | 10033340 | 1.87 | 76 | 03 | 2016-08-08 | 2016-08-08 | IBRUTINIB | 02 | N | IBRUTINIB | 100009879 |
| 10439141 | 10033341 | 1.52 | null | Curative (C) | 2019-03-16 | 2019-03-31 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100123157 |
| 10439146 | 10033342 | 1.86 | null | null | 2021-09-17 | 2021-09-28 | Capecitabine + Oxaliplatin 21day | 02 | null | RITUXIMAB | 100313389 |
| 10439150 | 10033343 | 1.68 | 60 | Palliative (P) | 2018-02-01 | 2018-02-11 | Rituximab | 02 | null | RITUXIMAB | 100108924 |
| 10439155 | 10033344 | 1.84 | 62.7 | 03 | 2017-12-31 | 2018-01-08 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 100678006 |
| 10439211 | 10033345 | 1.63 | 83 | Curative (C) | 2018-05-19 | 2018-05-22 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 100406626 |
| 10439214 | 10033346 | 1.85 | 64.9 | Adjuvant (A) | null | 2020-03-29 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100701468 |
| 10439217 | 10033347 | 1.65 | 59.3 | Palliative (P) | 2012-02-17 | 2016-02-20 | IBRUTINIB | 02 | N | IBRUTINIB | 101814915 |
| 10439231 | 10033348 | 1.6 | 85 | null | 2017-05-16 | 2017-05-16 | Capecitabine | 02 | null | CAPECITABINE | 101185309 |
| 10439232 | 10033349 | null | null | null | 2016-04-10 | 2016-08-26 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100005078 |
| 10439236 | 10033350 | 1.72 | 70 | null | 2019-09-19 | 2019-10-01 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 101540712 |